NCT03322540 Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) Status COMPLETED Phase PHASE2
NCT03321747 Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung Status TERMINATED Phase PHASE1
NCT03317080 Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer Status UNKNOWN Phase N/A
NCT03313544 Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1 Status UNKNOWN Phase PHASE4
NCT03309462 Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy Status COMPLETED Phase NA
NCT03305978 Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. Status COMPLETED Phase NA
NCT03302221 Regional Haemodynamic Changes in Radial Artery Assessment With Continuous Pulsed-wave Doppler Ultrasound Status WITHDRAWN Phase PHASE4
NCT03292133 A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03290677 Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy Status COMPLETED Phase NA
NCT03290534 Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® Status RECRUITING Phase PHASE2
NCT03274609 CT-controlled Advanced Navigation Techniques for Transbronchial Pulmonary Lesion Access; Evaluation of Augmented Fluoroscopy Bronchoscopic Navigation Based Diagnostic Yield Status COMPLETED Phase N/A